B. Bienvenu

发表

Peripheral CD8+CD25+ T Lymphocytes from MHC Class II-Deficient Mice Exhibit Regulatory Activity1

C. Bécourt, C. Auffray, B. Bienvenu, 2005, The Journal of Immunology.

Treatment of Systemic Necrotizing Vasculitides in Patients over 65 Years Results of the Multicenter Randomized CORTAGE Trial

P. Ravaud, J. Reny, D. Blockmans, 2014 .

Treatment of systemic necrotizing vasculitides in patients ≥ 65 years old: Results of the multicenter randomized CORTAGE trial

P. Ravaud, L. Mouthon, J. Reny, 2013 .

a non-lymphopenic environment Self-recognition is crucial for maintaining the peripheral CD4+ T cell pool in

C. Bécourt, B. Bienvenu, Bruno Martin, 2013 .

Self-recognition is crucial for maintaining the peripheral CD4+ T-cell pool in a nonlymphopenic environment.

C. Bécourt, B. Bienvenu, Bruno Martin, 2006, Blood.

Management of giant cell arteritis: Recommendations of the French Study Group for Large Vessel Vasculitis (GEFA).

F. Galateau-Sallé, B. Bonnotte, L. Mouthon, 2016, La Revue de medecine interne.

Superior efficacy and similar safety of double dose anakinra in Erdheim-Chester disease after single dose treatment

F. Galateau-Sallé, J. Emile, A. Aouba, 2018, Oncoimmunology.

Single-center, single-dose, open-label, randomized, two-period crossover study on the bioavailability of methotrexate administered using a novel prefilled, needle-free delivery system

J. Gottenberg, A. Aouba, C. Verstuyft, 2017, Current medical research and opinion.

Vasculitis secondary to anti-C1q antibodies induced by Toxocariasis

B. Bienvenu, N. Martin Silva, H. Boysson, 2015, Infection.

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials

R. Collins, C. Gordon, D. Isenberg, 2016, Arthritis & rheumatology.

Diagnostic Value of 18F-FDG PET/CT vs. Chest-Abdomen-Pelvis CT Scan in Management of Patients with Fever of Unknown Origin, Inflammation of Unknown Origin or Episodic Fever of Unknown Origin: A Comparative Multicentre Prospective Study

O. Decaux, P. Preux, J. Monteil, 2022, Journal of clinical medicine.

Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease.

L. Mouthon, O. Launay, C. Henegar, 2009, Medecine et maladies infectieuses.

Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients

E. Hachulla, J. Viallard, P. Clerson, 2018, Journal of Clinical Immunology.

Contribution of diagnostic tests for the etiological assessment of uveitis, data from the ULISSE study (Uveitis: Clinical and medicoeconomic evaluation of a standardized strategy of the etiological diagnosis).

E. Decullier, A. Bron, F. Mouriaux, 2018, Autoimmunity reviews.

Randomized Controlled Trial Evaluating a Standardized Strategy for Uveitis Etiologic Diagnosis (ULISSE).

E. Decullier, A. Bron, F. Mouriaux, 2017, American journal of ophthalmology.

Pulmonary Fibrosis in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis

P. Grenier, B. Housset, M. Resche-Rigon, 2014, Medicine.

French recommendations for the management of Takayasu’s arteritis

J. Alsac, L. Chiche, L. Arnaud, 2021, Orphanet Journal of Rare Diseases.

Specific Follicular Helper T Cell Signature in Takayasu Arteritis

J. Pouchot, D. Klatzmann, D. Sène, 2021, Arthritis & rheumatology.

[Ophthalmological complications of giant cell arteritis].

F. Mouriaux, B. Bienvenu, S. Coffin-Pichonnet, 2013, Journal francais d'ophtalmologie.

Treatment of giant-cell arteritis, a literature review

B. Bienvenu, H. de Boysson, M. Samson, 2017, Modern rheumatology.

Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study

D. Saadoun, A. Daumas, C. Blanchard-Delaunay, 2019, Clinical Rheumatology.

Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients.

B. Bonnotte, A. Aouba, A. Manrique, 2018, Autoimmunity reviews.

Giant-cell arteritis: concordance study between aortic CT angiography and FDG-PET/CT in detection of large-vessel involvement

A. Aouba, A. Manrique, N. Aide, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Repetitive 18F-FDG-PET/CT in patients with large-vessel giant-cell arteritis and controlled disease.

D. Huglo, J. Monteil, A. Aouba, 2017, European journal of internal medicine.

Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?

A. Aouba, A. Manrique, M. Lambert, 2017, The American journal of medicine.

Giant-cell arteritis without cranial manifestations

A. Aouba, A. Manrique, M. Lambert, 2016, Medicine.

Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.

C. Pagnoux, B. Bienvenu, C. Créveuil, 2013, Seminars in arthritis and rheumatism.

Giant Cell Arteritis–related Stroke: A Retrospective Multicenter Case-control Study

B. Bonnotte, A. Aouba, E. Touzé, 2017, The Journal of Rheumatology.

F-fluorodeoxyglucose positron emission of subsequent aortic complications in giant-cell arteritis

D. Huglo, E. Hachulla, A. Aouba, 2016 .

Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factors.

L. Mouthon, C. Ribi, X. Puéchal, 2014, Autoimmunity reviews.

Role of iconographic examinations in the treatment algorithm in Erdheim-Chester disease.

A. Aouba, O. Hermine, D. Launay, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anti‐IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Data on Seventeen Patients

V. Cottin, L. Mouthon, A. Coste, 2016, Arthritis & rheumatology.

Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides.

B. Bonnotte, L. Mouthon, J. Sibilia, 2013, Presse medicale.

Glutathione S Transferases Polymorphisms Are Independent Prognostic Factors in Lupus Nephritis Treated with Cyclophosphamide

E. Daugas, D. Chauveau, N. Costedoat-Chalumeau, 2016, PloS one.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.

L. Mouthon, F. Maurier, J. Viallard, 2013, Arthritis and rheumatism.

Indications for biotherapy in systemic vasculitides

L. Mouthon, L. Guillevin, C. Pagnoux, 2007, Clinical reviews in allergy & immunology.

Sustained Remission of Granulomatosis With Polyangiitis After Discontinuation of Glucocorticoids and Immunosuppressant Therapy: Data From the French Vasculitis Study Group Registry

E. Thervet, C. Charasse, L. Mouthon, 2021 .

Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody–associated Vasculitis: Results from a French Retrospective Monocentric Cohort

A. Aouba, B. Bienvenu, T. Lobbedez, 2019, The Journal of Rheumatology.

Coronary vasculitis associated with T-cell prolymphocytic leukemia.

R. Sabatier, P. Guilpain, B. Bienvenu, 2014, Joint, bone, spine : revue du rhumatisme.

Vasculitis associated with large granular lymphocyte (LGL) leukemia: presentation and treatment outcomes of 11 cases.

E. Lazaro, J. Rey, N. Schleinitz, 2013, Seminars in arthritis and rheumatism.

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA), polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) with no initial Five-Factor Score-defined poor-prognosis factors (FFS = 0): Baseline factors associated with cytotoxic agent and immunomodulator prescription

L. Mouthon, C. Ribi, X. Puéchal, 2013 .

Wegener’s Granulomatosis Strictly and Persistently Localized to One Organ Is Rare: Assessment of 16 Patients from the French Vasculitis Study Group Database

O. Decaux, L. Guillevin, A. Bérézné, 2011, The Journal of Rheumatology.

AutoimmunityCD8+ T Cell-Mediated Regulatory CD4+ T Cells Are Crucial for

B. Bienvenu, Bruno Martin, B. Lucas, 2013 .

Regulatory CD4+ T Cells Are Crucial for Preventing CD8+ T Cell-Mediated Autoimmunity1

B. Bienvenu, Bruno Martin, B. Lucas, 2008, The Journal of Immunology.

Regulatory Activity MHC Class II-Deficient Mice Exhibit T Lymphocytes from + CD 25 + Peripheral CD 8

C. Auffray, B. Bienvenu, Bruno Martin, 2005 .

Suppression of CD4+ T Lymphocyte Effector Functions by CD4+CD25+ Cells In Vivo1

B. Bienvenu, Bruno Martin, C. Cordier, 2004, The Journal of Immunology.

Lymphopenia-induced spontaneous T-cell proliferation as a cofactor for autoimmune disease development.

F. Lepault, C. Auffray, B. Bienvenu, 2009, Blood.

Working diagnosis of a distinct d Giant-cell arteritis without cranial manifestations isease pattern

A. Aouba, A. Manrique, M. Lambert, 2016 .

Excessive interleukin-15 transpresentation endows NKG2D+CD4+ T cells with innate-like capacity to lyse vascular endothelium in granulomatosis with polyangiitis (Wegener's).

A. Karras, L. Guillevin, S. Caillat-Zucman, 2011, Arthritis and rheumatism.

Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?

S. Dollfus, Vincent Marzloff, B. Bienvenu, 2016, Medicine.

Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study

N. Benech, J. Reuter, F. Lescure, 2021, Clinical Microbiology and Infection.

Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.

J. Piette, X. Mariette, D. Sène, 2015, Autoimmunity reviews.

Concordance of Time-of-Flight MRA and Digital Subtraction Angiography in Adult Primary Central Nervous System Vasculitis

O. Naggara, O. Detante, G. Boulouis, 2017, American Journal of Neuroradiology.

Fourteen-day survival among older adults with severe infection with severe acute respiratory syndrome coronavirus 2 treated with corticosteroid: a cohort study

N. Benech, J. Reuter, F. Lescure, 2021, Clinical Microbiology and Infection.

Biotherapies in inflammatory ocular disorders: Interferons, immunoglobulins, monoclonal antibodies.

D. Sène, L. Kodjikian, P. Cacoub, 2013, Autoimmunity reviews.

Observational Study of a French and Belgian Multicenter Cohort of 23 Patients Diagnosed in Adulthood With Mevalonate Kinase Deficiency

D. Maucort-Boulch, I. Touitou, L. Cuisset, 2016, Medicine.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

E. Andrès, G. Mahé, L. Chiche, 2018, Autoimmunity reviews.

Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial.

L. Mouthon, X. Puéchal, M. Hamidou, 2017, Clinical and experimental rheumatology.

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Respiratory Medicine.

Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial

A. Aouba, A. Mékinian, J. Courjon, 2022, PloS one.

Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review

E. Hachulla, A. Aouba, P. Quartier, 2018, The Journal of Rheumatology.

Deficiency : A Multicenter Retrospective Study in 13 Adult Patients and Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase

A. Aouba, P. Quartier, A. Hot, 2017 .

Tocilizumab and COVID-19: Timing of administration assessment

A. Mékinian, K. Lacombe, R. Dhôte, 2021, Infectious Diseases Now.

Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients

A. Bura, J. Emmerich, J. Fiessinger, 2004, Journal of thrombosis and haemostasis : JTH.

A cohort study of enfuvirtide immunological and virological efficacy in clinical practice

M. Pietri, P. Lebon, O. Launay, 2006, Journal of medical virology.

Treatment of Systemic Necrotizing Vasculitides in Patients Aged Sixty‐Five Years or Older: Results of a Multicenter, Open‐Label, Randomized Controlled Trial of Corticosteroid and Cyclophosphamide–Based Induction Therapy

P. Ravaud, L. Mouthon, J. Reny, 2015, Arthritis & rheumatology.

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients *

F. Carrat, P. Fenaux, T. Cluzeau, 2021, The British journal of dermatology.

Urogenital Manifestations in Wegener Granulomatosis: A Study of 11 Cases and Review of the Literature

J. Dufour, O. Decaux, C. Broussolle, 2012, Medicine.

Maintenance therapy is associated with better long-term outcomes in adult patients with primary angiitis of the central nervous system

O. Naggara, O. Detante, G. Boulouis, 2017, Rheumatology.

Analysis of Wegener’s Granulomatosis Responses to Rituximab: Current Evidence and Therapeutic Prospects

A. Aouba, L. Guillevin, A. Mahr, 2008, Clinical reviews in allergy & immunology.

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

F. Gray, D. Salmon, B. Bienvenu, 2005, Acta Neuropathologica.

Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

L. Mouthon, A. Aouba, L. Guillevin, 2012, The Journal of Rheumatology.

Un diagnostic qui aura pris du temps

V. Ribrag, D. Ghez, B. Bienvenu, 2013 .

Infections Revealing Complement Deficiency in Adults

F. Lucht, B. Fantin, D. Boutboul, 2016, Medicine.

Antifungal Therapy of Aspergillus Invasive Otitis Externa: Efficacy of Voriconazole and Review

P. Herman, M. Mamzer, O. Lortholary, 2008, Antimicrobial Agents and Chemotherapy.

Chronic urticaria and monoclonal IgM gammopathy (Schnitzler syndrome): report of 11 cases treated with pefloxacin.

M. Rybojad, B. Arnulf, J. Brouet, 2007, Archives of dermatology.

Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database.

L. Mouthon, R. Seror, C. Henegar, 2010, Arthritis and rheumatism.

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia

X. Troussard, A. Aouba, A. Borel‐Derlon, 2016, Medicine.

[Treatment of subcutaneous calcinosis in systemic disorders].

B. Bienvenu, 2014, La Revue de medecine interne.

Tumoral Calcinosis During the Course of Systemic Sclerosis

B. Bienvenu, A. Audemard, G. Maigné, 2015, The Journal of Rheumatology.

Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis

P. Ducrotte, M. Antonietti, E. Hachulla, 2014, Alimentary pharmacology & therapeutics.

Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis

J. Pouchot, A. Duhamel, L. Mouthon, 2020, Arthritis Research & Therapy.

Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature

L. Dauchet, J. Giovannelli, L. Mouthon, 2019, Arthritis Research & Therapy.

Neutrophilic Dermatoses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

A. Aouba, O. Meyer, A. Néel, 2016, Medicine.

Complete remission in refractory relapsing polychondritis with intravenous immunoglobulins.

A. Aouba, L. Guillevin, A. Mahr, 2008, Clinical and experimental rheumatology.

Evaluating the cost-consequence of a standardized strategy for the etiological diagnosis of uveitis (ULISSE study)

E. Decullier, A. Bron, F. Mouriaux, 2020, PloS one.

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial

E. Vicaut, S. Rebaudet, M. Briet, 2021, Clinical Microbiology and Infection.

Ehlers-Danlos Syndrome, Hypermobility Type: Impact of Somatosensory Orthoses on Postural Control (A Pilot Study)

C. Chesneau, P. Leconte, L. Decker, 2017, Front. Hum. Neurosci..

Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors.

L. Mouthon, C. Ribi, X. Puéchal, 2014, Autoimmunity reviews.

Adding Azathioprine to Remission‐Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

G. Baron, P. Ravaud, L. Mouthon, 2017, Arthritis & rheumatology.

Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case

A. Aouba, B. Bienvenu, S. Deshayes, 2016, Osteoporosis International.

Idiopathic hypertrophic pachymeningitis presenting with occipital neuralgia.

P. Busson, J. Constans, B. Bienvenu, 2015, African Health Sciences.

Rationale and efficacy of interleukin-1 targeting in Erdheim-Chester disease.

F. Galateau-Sallé, H. Bensadoun, A. Aouba, 2010, Blood.

Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature.

V. Cottin, L. Mouthon, F. Maurier, 2017, Autoimmunity reviews.

Superior efficacy and tolerance of reduced doses of vemurafenib plus anakinra in Erdheim-Chester disease: Towards the paradigm of combined targeting and immune therapies

F. Galateau-Sallé, J. Emile, A. Aouba, 2016, Acta oncologica.

Plasma exchanges for the treatment of severe systemic necrotizing vasculitides in clinical daily practice: Data from the French Vasculitis Study Group.

D. Chauveau, L. Mouthon, J. Aniort, 2015, Journal of autoimmunity.

Immunogenicity and reactogenicity of heterologous and homologous mRNA-1273 and BNT162b2 vaccination: A multicenter non-inferiority randomized trial

A. Rousseau, T. Simon, B. Laviolle, 2022, eClinicalMedicine.

Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients

L. Mouthon, O. Launay, C. Henegar, 2008, Annals of the rheumatic diseases.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

F. Rieux-Laucat, A. Fischer, J. Jais, 2019, Journal of Clinical Immunology.

A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?

R. Jaussaud, P. Clerson, P. Cherin, 2017, Patient preference and adherence.

Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort “Visages”

R. Jaussaud, E. Hachulla, P. Clerson, 2016, Orphanet Journal of Rare Diseases.

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

F. Rieux-Laucat, A. Fischer, J. Jais, 2017, The Journal of allergy and clinical immunology.

Early-onset hypogammaglobulinemia: A survey of 44 patients.

F. Rieux-Laucat, A. Fischer, C. Picard, 2015, The Journal of allergy and clinical immunology.

Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study.

P. Fenaux, L. Galicier, H. Coelho, 2022, Blood.

Neutropenia in Patients with Common Variable Immunodeficiency: a Rare Event Associated with Severe Outcome

F. Rieux-Laucat, É. Oksenhendler, S. Hanein, 2017, Journal of Clinical Immunology.

Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group

M. Dougados, M. Humbert, G. Baron, 2022, eClinicalMedicine.

Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial

E. Vicaut, M. Dougados, M. Humbert, 2021, The Lancet Rheumatology.

Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis

John O. Prior, D. Agostini, J. Parienti, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Adult primary angiitis of the central nervous system: isolated small-vessel vasculitis represents distinct disease pattern

O. Naggara, G. Boulouis, A. Aouba, 2016, Rheumatology.

Primary Angiitis of the Central Nervous System: Description of the First Fifty‐Two Adults Enrolled in the French Cohort of Patients With Primary Vasculitis of the Central Nervous System

Catherine Oppenheim, Emmanuel Touzé, Olivier Detante, 2014, Arthritis & rheumatology.

Aortic involvement in relapsing polychondritis.

L. Arnaud, Z. Amoura, I. Marie, 2017, Joint, bone, spine : revue du rhumatisme.

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis

C. Creuzot-Garcher, B. Bonnotte, V. Quipourt, 2021, Clinical & translational immunology.

Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

X. Mariette, W. Ng, Z. Amoura, 2016, Arthritis & rheumatology.

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.

D. Maucort-Boulch, S. Vukusic, Z. Amoura, 2017, Seminars in arthritis and rheumatism.

Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network

L. Biard, D. Sène, E. Hachulla, 2016, Arthritis & rheumatology.

JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis

W. Stenzel, G. Butler-Browne, V. Mouly, 2018, Brain : a journal of neurology.

Tumor-Like Presentation of Primary Angiitis of the Central Nervous System

Emmanuel Touzé, Olivier Detante, Olivier Naggara, 2016, Stroke.

[Systemic sclerosis and occupational exposures: About a case in a driller-powderman].

B. Clin, M. Boulanger, B. Bienvenu, 2015, La Revue de medecine interne.

Melanoma-Associated Retinopathy Treated with Ipilimumab Therapy

B. Dréno, B. Bienvenu, A. Dompmartin, 2013, Dermatology.

Prevalence of Raynaud Phenomenon and Nailfold Capillaroscopic Abnormalities in Fabry Disease

R. Jaussaud, A. Aouba, J. Parienti, 2015, Medicine.

Chronic Urticaria and Monoclonal IgM Gammopathy

M. Rybojad, B. Arnulf, J. Brouet, 2017 .

The spectrum of granulomatous vasculitides

L. Guillevin, C. Pagnoux, B. Bienvenu, 2006 .

Patients with systemic inflammatory and autoimmune diseases are at risk of vaccine-preventable illnesses.

L. Mouthon, A. Aouba, P. Lebon, 2011, Rheumatology.

Characteristics and Management of IgA Vasculitis (Henoch‐Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey

E. Thervet, Z. Amoura, F. Maurier, 2017, Arthritis & rheumatology.

Thoracic involvement and imaging patterns in IgG4-related disease

P. Chanez, J. Gaubert, M. Ebbo, 2021, European Respiratory Review.

Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study

G. Choukroun, E. Hachulla, D. Launay, 2018, BMC Nephrology.

Efficacy of Anakinra for Various Types of Crystal-Induced Arthritis in Complex Hospitalized Patients: A Case Series and Review of the Literature

A. Aouba, L. Frenzel, O. Hermine, 2015, Mediators of inflammation.

Efficacy and safety of TNF antagonists in ocular sarcoidosis: data from the French registry STAT

D. Maucort-Boulch, S. Vukusic, C. Broussolle, 2017, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Characterisation of a high-risk profile for maternal thrombotic and severe haemorrhagic complications in pregnant women with antiphospholipid syndrome in France (GR2): a multicentre, prospective, observational study

C. Cazalets, P. Dieudé, X. Mariette, 2022, The Lancet Rheumatology.

AL amyloidosis with temporal artery involvement simulates giant-cell arteritis.

M. Macro, B. Bienvenu, A. Audemard, 2012, Joint, bone, spine : revue du rhumatisme.

Towards an optimal semiquantitative approach in giant cell arteritis: an 18F-FDG PET/CT case-control study

D. Agostini, J. Parienti, G. Bouvard, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.

X. Mariette, R. Loffroy, B. Bonnotte, 2018, European journal of internal medicine.

Loss of base‐to‐apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?

E. Saloux, B. Bienvenu, F. Labombarda, 2017, Echocardiography.

Systematic retrospective study on 64 patients anti-Mi2 dermatomyositis: a classic skin rash with a necrotizing myositis and high risk of malignancy.

V. Jooste, W. Stenzel, M. Richard, 2020, Journal of the American Academy of Dermatology.

Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study.

M. Dougados, C. Cazalets, P. Dieudé, 2023, The Lancet. Rheumatology.

Assessment and effective targeting of Interleukin-1 in multicentric reticulohistyocytosis.

A. Aouba, S. Georgin-lavialle, S. Fraitag, 2015, Joint, bone, spine : revue du rhumatisme.

Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980–2011)

A. Aouba, G. Rey, A. Mahr, 2018, Rheumatology.

Revised primary angiitis of the central nervous system: Description of the first 52 adults enrolled in the french COVAC' cohort.

Catherine Oppenheim, Emmanuel Touzé, Olivier Detante, 2014 .

[Temporomandibular disorders and Ehlers-Danlos syndrome, hypermobility type: A case-control study].

H. Bénateau, B. Bienvenu, A. Veyssière, 2016, Revue de stomatologie, de chirurgie maxillo-faciale et de chirurgie orale.

Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis

G. Zalcman, E. Bergot, A. Manrique, 2018, Annals of Nuclear Medicine.

Effectiveness and tolerance of off-label use of tocilizumab in autoimmune diseases: a multicenter study.

L. Chiche, B. Bienvenu, G. Urbanski, 2020, Joint, bone, spine : revue du rhumatisme.

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

X. Mariette, J. Gottenberg, V. Devauchelle-Pensec, 2022, RMD Open.